Chita, Japan

Kasumari Nakao

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kasumari Nakao. Retrieved from https://idiyas.com/inventor/kasumari-nakao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kasumari Nakao

Introduction

Kasumari Nakao is a notable inventor based in Chita-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as COX-2 inhibitors. His work has implications for pain management and inflammation treatment.

Latest Patents

Nakao holds a patent for "Indole compounds as COX-2 inhibitors." This invention provides a compound of a specific formula that has potential therapeutic applications. He has 1 patent to his name, showcasing his innovative approach to drug development.

Career Highlights

Nakao is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to contribute to cutting-edge research and development in the pharmaceutical industry. His expertise in medicinal chemistry has been instrumental in advancing new therapeutic options.

Collaborations

Throughout his career, Nakao has collaborated with esteemed colleagues, including Rodney W. Stevens and Kiyoshi Kawamura. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Kasumari Nakao's contributions to the field of pharmaceuticals, particularly through his patent on COX-2 inhibitors, highlight his role as an influential inventor. His work continues to impact the development of new treatments for various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…